Form 8-K - Current report:
SEC Accession No. 0001437749-25-019983
Filing Date
2025-06-10
Accepted
2025-06-10 16:17:53
Documents
13
Period of Report
2025-06-10
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K eton20250530_8k.htm   iXBRL 8-K 27950
  Complete submission text file 0001437749-25-019983.txt   161072

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA eton-20250610.xsd EX-101.SCH 3579
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eton-20250610_def.xml EX-101.DEF 11807
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE eton-20250610_lab.xml EX-101.LAB 15858
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eton-20250610_pre.xml EX-101.PRE 12022
15 EXTRACTED XBRL INSTANCE DOCUMENT eton20250530_8k_htm.xml XML 2950
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

EIN.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38738 | Film No.: 251037329
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)